secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bionano Genomics, Inc. (BNGO)
CIK:        0001411690
Form:       8-K
Filed at:   2023-10-11T23:59:59+00:00
Accession:  0001140361-23-047688
Event type: debt
Sentiment:  negative
Materiality: 0.85
Item codes: 1.01, 2.02, 2.03, 2.05, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bionano Genomics closes $80M convertible note financing with High Trail; plans 17% workforce reduction
--------------------------------------------------------------------------------

- Entered securities purchase agreement to issue $45M registered and $35M private senior secured convertible notes due 2025; warrants to buy up to 21.66M shares at $3.1855.
- Net proceeds estimated at $75.6M; proceeds used for working capital and general corporate purposes including R&D and capex.
- Reduces headcount by ~66 employees (17% of full-time staff) as part of corporate reorganization to save ~$33M annually starting 2024.
- Notes carry initial conversion price of ~$2.8638 per share; no regular interest; repayment at 115% of principal at maturity.
- Issued press release announcing preliminary Q3 2023 results; specific figures not provided in filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1411690/000114036123047688/0001140361-23-047688-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1411690/000114036123047688/ef20012228_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-23-047688

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer